__timestamp | Bristol-Myers Squibb Company | Walgreens Boots Alliance, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 5699000000 | 17992000000 |
Thursday, January 1, 2015 | 5001000000 | 22400000000 |
Friday, January 1, 2016 | 5002000000 | 23910000000 |
Sunday, January 1, 2017 | 4849000000 | 23813000000 |
Monday, January 1, 2018 | 4551000000 | 24694000000 |
Tuesday, January 1, 2019 | 4871000000 | 23557000000 |
Wednesday, January 1, 2020 | 7661000000 | 25436000000 |
Friday, January 1, 2021 | 7690000000 | 24586000000 |
Saturday, January 1, 2022 | 7814000000 | 27295000000 |
Sunday, January 1, 2023 | 7772000000 | 34205000000 |
Monday, January 1, 2024 | 8414000000 | 28113000000 |
In pursuit of knowledge
In the ever-evolving landscape of corporate finance, understanding Selling, General, and Administrative (SG&A) expenses is crucial for evaluating a company's operational efficiency. Bristol-Myers Squibb Company, a leader in the pharmaceutical industry, and Walgreens Boots Alliance, Inc., a retail giant, offer a fascinating comparison. From 2014 to 2023, Bristol-Myers Squibb's SG&A expenses fluctuated, peaking in 2022 with a 72% increase from its 2018 low. Meanwhile, Walgreens Boots Alliance consistently reported higher SG&A expenses, reflecting its expansive retail operations. By 2023, Walgreens' SG&A expenses were approximately 3.3 times those of Bristol-Myers Squibb. This disparity highlights the contrasting business models and operational scales of these two industry leaders. Notably, data for Bristol-Myers Squibb in 2024 is missing, underscoring the dynamic nature of financial reporting.
Bristol-Myers Squibb Company vs Alnylam Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Bristol-Myers Squibb Company vs Viking Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Protagonist Therapeutics, Inc.
Bristol-Myers Squibb Company vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Incyte Corporation vs Walgreens Boots Alliance, Inc.
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. vs TG Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Novavax, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Taro Pharmaceutical Industries Ltd.